Otsuka Holdings Co., Ltd.: all 780 studies

Page 6 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy VolunteersCompletedNCT04150172Phase 1
• To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy VolunteersCompletedNCT04150146Phase 1
• A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With SchizophreniaTerminatedNCT04109950Phase 3
• Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol DependenceCompletedNCT04107051
• A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melatonin in Healthy AdultsCompletedNCT04067791Phase 1
• A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCLCompletedNCT04049825Phase 1
• Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53TerminatedNCT03975387Phase 1
• Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney DiseaseCompletedNCT03949894Phase 4
• Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic SyndromesActive, not recruitingNCT03906695Phase 1
• Safety and Efficacy of Brexpiprazole in the Treatment of SchizophreniaCompletedNCT03874494Phase 3
• Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT03872596Phase 1
• A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I DisorderCompletedNCT03854409Phase 1
• Effect of Food on Blood Levels of ASTX727CompletedNCT03813186Phase 1
• The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese SubjectsCompletedNCT03734354Phase 1
• The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy SubjectsCompletedNCT03734302Phase 1
• Iclusig PMS in CML or Ph+ALL PatientsStatus unknownNCT03709017
• Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.CompletedNCT03605251Phase 2
• Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDSCompletedNCT03502668Phase 1/2
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's SyndromeCompletedNCT03487783Phase 3
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic DisorderCompletedNCT03487770Phase 3
• The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive DisorderTerminatedNCT03487198Phase 3
• Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TBCompletedNCT03470233
• A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 AbnormalitiesTerminatedNCT03410927Phase 1
• Samsca PMS in ADPKD PatientsCompletedNCT03406286
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedNCT03393520Phase 3
• Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 DisorderCompletedNCT03386851
• Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult ParticipantsCompletedNCT03381664Phase 1
• MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical AntipsychoticsCompletedNCT03376763Phase 4
• Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System DisordersCompletedNCT03292848Phase 1
• Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03287505Phase 1
• PK Study of Aripiprazole IM Depot for Chinese Patients With SchizophreniaCompletedNCT03285503Phase 1
• A Trial of C13-CAC Breath Test in PPI Resistant GERD PatientsCompletedNCT03284177Phase 2
• Aripiprazole IM Depot in the Acute Treatment of Adults With SchizophreniaCompletedNCT03172871Phase 3
• Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With SchizophreniaCompletedNCT03150771Phase 1
• The CHOICE RegistryTerminatedNCT03148093
• Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in SpainCompletedNCT03130478
• Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset SchizophreniaStatus unknownNCT03130465
• Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in ItalyCompletedNCT03005769
• A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or LymphomaTerminatedNCT02978235Phase 1
• Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With SchizophreniaTerminatedNCT02968121Phase 1
• A Study of TAS-116 in Patients With Solid TumorsCompletedNCT02965885Phase 1
• Canadian Medical Assessment of JINARC™ Outcomes RegistryCompletedNCT02925221
• A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in EuropeStatus unknownNCT02848521
• A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy SubjectsTerminatedNCT02827513Phase 1
• Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing SurveillanceCompletedNCT02730390
• An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in ItalyCompletedNCT02573077
• Study of TAS3681 in Metastatic Castration Resistant Prostate CancerCompletedNCT02566772Phase 1
• A Study of TAS-303 in Female Patients With Stress Urinary IncontinenceCompletedNCT02562807Phase 1
• Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and LymphomasActive, not recruitingNCT02503423Phase 1/2
• Influenza Challenge Study of VIS410 in Healthy VolunteersCompletedNCT02468115Phase 2
• A Trial of TAS-114 in Combination With S-1CompletedNCT02454062Phase 1
• An Investigation of TAS-119 MonotherapyTerminatedNCT02448589Phase 1
• A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic HyponatremiaWithdrawnNCT02442674Phase 3
• Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With SchizophreniaCompletedNCT02411695Phase 1
• Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult SubejctsCompletedNCT02402595Phase 1
• Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart FailureTerminatedNCT02352285Phase 4
• A Phase 1 Study Comparing AVP-786 With AVP-923CompletedNCT02336347Phase 1
• A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal ImpairmentCompletedNCT02301117Phase 1
• A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic ImpairmentCompletedNCT02301104Phase 1
• Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal CancerApproved for marketingNCT02286492
• Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid TumorCompletedNCT02250170Phase 1
• Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH MonitoringCompletedNCT02225067Phase 2
• Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityWithdrawnNCT02212613Phase 3
• A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy VolunteersCompletedNCT02196805Not applicable
• Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or PlaceboCompletedNCT02192554
• A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy VolunteersCompletedNCT02174835Phase 1
• A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy SubjectsCompletedNCT02174822Phase 1
• Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's TypeTerminatedNCT02168920Phase 3
• BioMimics 3D Stent Clinical Investigation: The Mimics StudyCompletedNCT02163863Not applicable
• Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentCompletedNCT02153502Phase 2
• A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant UsersCompletedNCT02144415Phase 1
• Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid TumorsTerminatedNCT02134067Phase 1
• To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia SubjectCompletedNCT02098460Phase 4
• Safety and Efficacy Study of Cilostazol to Treat Vasospastic AnginaCompletedNCT02094469Phase 3
• A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic AnginaCompletedNCT02087007Phase 3
• Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or SchizophreniaCompletedNCT02050854
• A Study of VIS410 to Assess Safety and PharmacokineticsCompletedNCT02045472Phase 1
• A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerTerminatedNCT02042885Phase 1/2
• Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid TumorsCompletedNCT02031055Phase 1
• A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid TumorsCompletedNCT02025803Phase 1
• Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With SchizophreniaCompletedNCT01994473Phase 1
• Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I DisorderWithdrawnNCT01981811Phase 2
• Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype CharacteristicsCompletedNCT01972711Phase 1
• A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)TerminatedNCT01942083Phase 1
• A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With SchizophreniaCompletedNCT01940159Phase 1
• OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.CompletedNCT01925521Phase 1
• A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.CompletedNCT01916447Phase 1
• A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based ChemotherapyTerminatedNCT01904253Phase 2
• Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPICompletedNCT01874522Phase 1
• Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid TumorsCompletedNCT01867879Phase 1
• Study Comparing the Pharmacokinetics of FTD as a Component of TAS-102 With FTD AloneCompletedNCT01867866Phase 1
• Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant TuberculosisCompletedNCT01856634Phase 1
• TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)CompletedNCT01789918Not applicable
• Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy VolunteersCompletedNCT01787747Phase 1
• A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020CompletedNCT01744808Phase 1
• Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes MellitusCompletedNCT01739829Phase 1/2
• Efficacy and Safety Study of Probucol in Patients With Diabetic NephropathyCompletedNCT01726816Phase 2
• Study of Arginine Free IED in Critically Ill Patients.CompletedNCT01713257Phase 4
• A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With CrizotinibCompletedNCT01712217Phase 1/2
• A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial DiseaseCompletedNCT01711333Phase 4

← Otsuka Holdings Co., Ltd. overview and focus areas